| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Financial Officer
1 company
Deptula-Hicks Darlene M serves as a SVP, Chief Financial Officer at PVLA. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $8K at current prices.
The biggest single holding is PVLA (~$8K) as SVP, Chief Financial Officer. Net of sales, the recent Form 4 record there shows accumulation of 5,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2016 | PVLA Palvella Therapeutics, Inc. | SVP, Chief Financial Officer | Buy | 5,000 | $1.66 | $8,300.00 | New |